- Bupa Platinum consultant
- Fee assured
- Verified account
- Open Referral network
Specialises in
- Urology
Offers
- Face-to-face consultations
- Video and telephone consultations
- Home chemotherapy
About me
Dr Philip Camilleri was appointed as Consultant Clinical Oncologist in 2006 having trained in Clinical Oncology in Oxford
Dr Camilleri currently specialises in urological cancers, specifically prostate, bladder, testicular cancers. He provides chemotherapy, hormonal as well as radiotherapy treatment.
Dr Camilleri delivers prostate brachytherapy at the Oxford Cancer Centre. He also provides Intensity Modulated Radiotherapy (IMRT) with Image guidance (IGRT) for prostate cancers. He is involved in research for most urological cancers.
Areas of interest
Prostate disease including prostate cancer; Testicular cancer; Bladder cancer; Urological oncology treating with MR guided Radiotherapy, IMRT, IGRT and brachytherapy; Chemotherapy including docetaxel and cabazitaxel; Hormone therapy including abiraterone (zytiga) and enzalutamide (xtandi); Bone therapy with zometa and denosumab; Radium 223 therapy (xofigo)
Medical secretaries
- Bridget Eley and Jade Moss
- 55 Hightown Road Banbury OX16 9BE
- 07854 411376
- 01604 620730
- pa.drcamilleri@genesiscar.co.uk
Information for healthcare professionals (Bupa patients only, last 12 months)
-
20365
Follow-up out-patient consultation - remote - (>50)
-
X0004
Clinical supervision and planning for the delivery of chemotherapy and/or systemic anti-cancer therapy for 1-28 days - (5-50)
GenesisCare, Oxford (1-5)
-
A1080
Stereotactic radiotherapy (SRT), second to fifth sessions, including adjustments, using Cyberknife or similar SRT technology - (5-50)
GenesisCare, Oxford (5-50)
-
A1070
Stereotactic radiotherapy (SRT), first/sole session using Cyberknife or similar SRT technology - (5-50)
GenesisCare, Oxford (5-50)
-
X6950
Clinical supervision of the planning of stereotactic radiosurgery e.g. SRT/SBRT and Gamma Knife - (5-50)
GenesisCare, Oxford (5-50)
- Show All (13 )...